Sernova Corp (SVA):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Sernova Corp (SVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C3305)・商品コード:DATA904C3305
・発行会社(調査会社):GlobalData
・発行日:2018年8月
・ページ数:26
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥73,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥109,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like environment for the long term survival and function of insulin producing islets for the treatment of diabetes. Sernova uses proprietary local immune protection technologies that protect therapeutic cells within the Cell Pouch from immune system. The company’s product portfolio addresses metabolic diseases such as insulin dependent diabetes and thyroid disease; and blood disorders such as hemophilia A; and other neurological ailments. Sernova is headquartered in London, Ontario, Canada.

Sernova Corp (SVA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sernova Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sernova Corp, Medical Devices Deals, 2012 to YTD 2018 9
Sernova Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sernova Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sernova Enters into Research Agreement with Massachusetts General Hospital 11
Sernova And Medicyte Enter Into Co-Development Agreement For Pouch/Upcyte Combination Product 12
Licensing Agreements 13
Sernova Enters into Licensing Agreement with University Health Network 13
Equity Offering 14
Sernova to Raise USD2.5 Million in Private Placement of Shares 14
Sernova Raises USD1.7 Million in Second and Final Tranche of Private Placement of Units 15
Sernova Raises USD1.6 Million in First Tranche of Private Placement of Units 17
Sernova Raises USD1.3 Million Private Placement of Shares 18
Sernova Completes Private Placement Of Units For US$2 Million 19
Sernova Completes Second Tranche Of Private Placement Of Units For US$0.14 Million 20
Sernova Corp – Key Competitors 21
Sernova Corp – Key Employees 22
Sernova Corp – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Government and Public Interest 24
Jun 05, 2017: Sernova Provides Company Outlook on Corporate and Clinical Developments 24
Other Significant Developments 25
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Sernova Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sernova Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sernova Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Sernova Corp, Medical Devices Deals, 2012 to YTD 2018 9
Sernova Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sernova Enters into Research Agreement with Massachusetts General Hospital 11
Sernova And Medicyte Enter Into Co-Development Agreement For Pouch/Upcyte Combination Product 12
Sernova Enters into Licensing Agreement with University Health Network 13
Sernova to Raise USD2.5 Million in Private Placement of Shares 14
Sernova Raises USD1.7 Million in Second and Final Tranche of Private Placement of Units 15
Sernova Raises USD1.6 Million in First Tranche of Private Placement of Units 17
Sernova Raises USD1.3 Million Private Placement of Shares 18
Sernova Completes Private Placement Of Units For US$2 Million 19
Sernova Completes Second Tranche Of Private Placement Of Units For US$0.14 Million 20
Sernova Corp, Key Competitors 21
Sernova Corp, Key Employees 22

List of Figures
Sernova Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sernova Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sernova Corp, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[Sernova Corp (SVA):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C3305)販売に関する免責事項を必ずご確認ください。
★調査レポート[Sernova Corp (SVA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆